Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.

Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder

Saxena, S · 1999 · Neuropsychopharmacology

Abstract

Previous positron emission tomography (PET) studies of patients with obsessive-compulsive disorder (OCD) have found elevated glucose metabolic rates in the orbitofrontal cortex (OFC) and caudate nuclei that normalize with response to treatment. Furthermore, OCD symptom provocation differentially activates specific subregions of the OFC, which have distinct patterns of connectivity and serve different functions. Therefore, we sought to determine the role of specific subregions of the OFC and associated subcortical structures in mediating OCD symptoms, by determining how glucose metabolism in these structures changed with paroxetine treatment of OCD patients. We also sought to determine whether pretreatment OFC metabolism would predict response to paroxetine, as it has for other OCD treatments. Twenty subjects with OCD received [18F]-fluorodeoxyglucose (FDG)-PET scans before and after 8 to 12 weeks of treatment with paroxetine, 40 mg/day. In patients who responded to paroxetine, glucose metabolism decreased significantly in right anterolateral OFC and right caudate nucleus. Lower pretreatment metabolism in both left and right OFC predicted greater improvement in OCD severity with treatment. These results add to evidence indicating that orbitofrontal-subcortical circuit function mediates the symptomatic expression of OCD. Specific subregions of the OFC may be differentially involved in the pathophysiology of OCD and/or its response to pharmacotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0893-133x(99)00082-2

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Cited by

See all 379

Metadata

Authors
Saxena, S.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Saxena, S
Venue
Neuropsychopharmacology
Published
1999-12
Volume
21
Issue
6
Pages
683-693
ISSN
0893-133X (ISSN-L)
OpenAlex
W2084388248
Cited by
379
References
55
Citations by year
2026: 3 · 2025: 10 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 14 · 2020: 2 · 2019: 8 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 25 · 2014: 19 · 2013: 19 · 2012: 17
FWCI
17.23
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy
  • Dana Foundation
  • National Alliance for Research on Schizophrenia and Depression
  • National Institutes of Health (5r01mh053565-03)
  • National Institute of Mental Health (R01 MH 53565-A)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
obsessive-compulsive disorder, paroxetine, orbitofrontal cortex, caudate nucleus, glucose metabolism, treatment response prediction, FDG-PET, symptom provocation
MeSH terms
Cerebral Cortex, Female, Frontal Lobe, Humans, Male, Obsessive-Compulsive Disorder, Predictive Value of Tests, Regression Analysis, Tomography, Emission-Computed, Selective Serotonin Reuptake Inhibitors, Paroxetine, Radiopharmaceuticals, Fluorodeoxyglucose F18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder. https://app.cochat.ai/papers/10.1016/s0893-133x(99)00082-2
The paper
Saxena, S. (1999). Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(99)00082-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.